Pfizer COVID-19 Vaccine Summary | Vaccines & Immunizations …
WEBAug 28, 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL …
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAug 22, 2024 · The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech...
Pfizer–BioNTech COVID-19 vaccine - Wikipedia
WEBThe Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials , logistics, and manufacturing.
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBDec 11, 2020 · The Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to: prevent COVID-19 in individuals 12 years of age and older, and. provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise.
The FDA just approved the new Covid vaccine: When to get it and …
WEBAug 22, 2024 · The Food and Drug Administration on Thursday approved the new Covid vaccines from Pfizer and Moderna. It’s the third time the vaccines have been updated to match circulating strains since the...
FDA Approves First COVID-19 Vaccine
WEBFDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease...
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization …
WEBThursday, August 22, 2024 - 02:15pm. View pdf copy Copy to clipboard Open in tab. The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older.
ACIP Evidence to Recommendations for Use of Pfizer-BioNTech …
WEBJul 23, 2024 · The Pfizer-BioNTech COVID-19 vaccine is recommended for people 16 years of age and older under FDA’s Biologics License Application (BLA) *Overall efficacy was calculated at ≥7 days after second dose of vaccine among persons without evidence of prior SARS-CoV-2 infection.
Pfizer-BioNTech COVID-19 Vaccine | FDA
WEBSep 11, 2023 · The Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19. The Pfizer-BioNTech...
ACIP Evidence to Recommendations for Use of Pfizer-BioNTech …
WEBSep 9, 2024 · The judgment of a plurality of Work Group members was that the Pfizer-BioNTech COVID-19 vaccine would probably increase health equity. Nearly an equal number thought the Pfizer-BioNTech COVID-19 vaccine would increase equity. The judgements of the remaining Work Group members were nearly equally distributed among the five other judgment options.